A mérsékelt alkoholfogyasztás csökkenti a cardiovascularis halálozást az átlagpopulációban. Viszonylag kevés vizsgálat jelent meg a fehérbor inzulinérzékenységre gyakorolt hatásával kapcsolatban. Célkitűzés: A szerzők a kis mennyiségű Pintes fehérbor fogyasztásának inzulinérzékenységre és egyéb anyagcsere-paraméterekre gyakorolt hatását vizsgálták. Módszer: A prospektív vizsgálatban 18 metabolikus szindrómás beteg vett részt. A betegek négy héten át Pintes bort fogyasztottak. A borfogyasztás előtt, illetve után meghatározták a klinikai paramétereket. Eredmények: A HOMA-IR szignifikáns mértékű csökkenést mutatott a fehérbor fogyasztását követően (2,28±2,04 vs. 1,08±0,6; p = 0,002). Nem változott a szérum összes koleszterin, az LDL-koleszterin, a triglicerid és az éhomi plazma vércukor szintje sem. Következtetések: A fehérbor fogyasztása javította az inzulinérzékenység mértékét metabolikus szindrómás betegekben. Orv. Hetil., 2012, 153, 861–865.
Hansel, B., Thomas, F., Pannier, B., et al.: Relationship between alcohol intake, health and social status and cardiovascular risk factors in the urban Paris-Ile-De-France Cohort: is the cardioprotective action of alcohol a myth? Eur. J. Clin. Nutr., 2010, 64, 561–568.
Pannier B. , 'Relationship between alcohol intake, health and social status and cardiovascular risk factors in the urban Paris-Ile-De-France Cohort: is the cardioprotective action of alcohol a myth? ' (2010 ) 64 Eur. J. Clin. Nutr. : 561 -568 .
Rimm, E. B., Williams, P., Fosher, K., et al.: Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br. Med. J., 1999, 319, 1523–1528.
Fosher K. , 'Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors ' (1999 ) 319 Br. Med. J. : 1523 -1528 .
Imhof, A., Froehlich, M., Brenner, H., et al.: Effect of alcohol consumption on systemic markers of inflammation. Lancet, 2001, 357, 763–767.
Brenner H. , 'Effect of alcohol consumption on systemic markers of inflammation ' (2001 ) 357 Lancet : 763 -767 .
Riserus, U., Ingelsson, E.: Alcohol intake, insulin resistance, and abdominal obesity in elderly men. Obesity, 2007, 15, 1766–1773.
Ingelsson E. , 'Alcohol intake, insulin resistance, and abdominal obesity in elderly men ' (2007 ) 15 Obesity : 1766 -1773 .
Beulens, J. W. J., Rimm, E. B., Hendriks, H. F. J., et al.: Alcohol consumption and type 2 diabetes. Diabetes, 2007, 56, 2388–2394.
Hendriks H. F. J. , 'Alcohol consumption and type 2 diabetes ' (2007 ) 56 Diabetes : 2388 -2394 .
Kim, S. H., Abbasi, F., Lamendola, C., et al.: Effect of moderate alcoholic beverage consumption on insulin sensitivity in insulin-resistant, nondiabetic individuals. Metabolism, 2009, 58, 387–392.
Lamendola C. , 'Effect of moderate alcoholic beverage consumption on insulin sensitivity in insulin-resistant, nondiabetic individuals ' (2009 ) 58 Metabolism : 387 -392 .
Napoli, R., Cozzolino, D., Guardasole, V., et al.: Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. Metabolism, 2005, 54, 306–313.
Guardasole V. , 'Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients ' (2005 ) 54 Metabolism : 306 -313 .
Fueki, Y., Miida, T., Wardaningsih, E., et al.: Regular alcohol consumption improves insulin resistance in healthy Japanese men independent of obesity. Clin. Chim. Acta, 2007, 382, 71–76.
Wardaningsih E. , 'Regular alcohol consumption improves insulin resistance in healthy Japanese men independent of obesity ' (2007 ) 382 Clin. Chim. Acta : 71 -76 .
Hungarian Tourism Co. [Magyar Turizmus Zrt.] http://itthon.hu/site/upload/mtrt/Turizmus_Bulletin/bulletin_2006_3/borfogyasztas.html [Hungarian]
Ambrus, L.: http://www.foodandwine.hu/2009/11/06/pintes-egy-novenyorszagi-hungarikum/ [Hungarian]
Bekő, G., Hagymási, K., Szentmihályi, K., et al.: Sex-dependent alterations in erythrocyte trace element levels and antioxidant status after a month of moderate daily red wine consumption. Eur. J. Gastroenterol. Hepatol., 2010, 22, 185–191.
Szentmihályi K. , 'Sex-dependent alterations in erythrocyte trace element levels and antioxidant status after a month of moderate daily red wine consumption ' (2010 ) 22 Eur. J. Gastroenterol. Hepatol. : 185 -191 .
Ábel, T., Fehér, J.: Effect of moderate alcohol consumption on insulin sensitivity. [A mérsékelt alkoholfogyasztás hatása az inzulinérzékenységre.] Orv. Hetil., 2009, 150, 2218–2221. [Hungarian]
Fehér J. , 'Effect of moderate alcohol consumption on insulin sensitivity. [A mérsékelt alkoholfogyasztás hatása az inzulinérzékenységre.] ' (2009 ) 150 Orv. Hetil. : 2218 -2221 .
Joosten, M. M., Beulens, J. W. J., Kersten, S., et al.: Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia, 2008, 51, 1375–1381.
Kersten S. , 'Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial ' (2008 ) 51 Diabetologia : 1375 -1381 .
Sierksma, A., van der Gaag, M. S., Kluft, C., et al.: Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels: a randomized, diet-controlled intervention study. Eur. J. Clin. Nutr., 2002, 56, 1130–1136.
Kluft C. , 'Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels: a randomized, diet-controlled intervention study ' (2002 ) 56 Eur. J. Clin. Nutr. : 1130 -1136 .
Davies, M. J., Baer, D. J., Judd, J. T., et al.: Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA, 2002, 287, 2559–2562.
Judd J. T. , 'Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial ' (2002 ) 287 JAMA : 2559 -2562 .
Ábel, T., Fehér, J.: Non-alcoholic fatty liver disease and cardiovascular risk. Hung. Med. J., 2008, 2, 509–518.
Fehér J. , 'Non-alcoholic fatty liver disease and cardiovascular risk ' (2008 ) 2 Hung. Med. J. : 509 -518 .
Baldeweg, S. E., Golay, A., Natali, A.: Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans: European Group for the Study of Insulin Resistance (EGIR). Eur. J. Clin. Invest., 2000, 30, 45–52.
Natali A. , 'Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans: European Group for the Study of Insulin Resistance (EGIR) ' (2000 ) 30 Eur. J. Clin. Invest. : 45 -52 .
Miyazaki, Y., Pipek, R., Mandarino, L. J., et al.: Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord., 2003, 27, 88–94.
Mandarino L. J. , 'Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients ' (2003 ) 27 Int. J. Obes. Relat. Metab. Disord. : 88 -94 .
Loebig, M., Klement, J., Schmoller, A., et al.: Evidence for relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men. PloS One, 2010, 5, e12610.
Schmoller A. , 'Evidence for relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men ' (2010 ) 5 PloS One : e12610 -.
Danesh, J., Collins, R., Appleby, P., et al.: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA, 1998, 279, 1477–1482.
Appleby P. , 'Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies ' (1998 ) 279 JAMA : 1477 -1482 .
Koenig, W., Wanner, K.: C-reactive protein and coronary artery disease – what is the link? Nephrol. Dial. Translpant., 1999, 14, 2798–2800.
Wanner K. , 'C-reactive protein and coronary artery disease – what is the link? ' (1999 ) 14 Nephrol. Dial. Translpant. : 2798 -2800 .
Imhof, A., Froehlich, M., Brenner, H., et al.: Effect of alcohol consumption on systemic markers of inflammation. Lancet, 2001, 357, 763–767.
Brenner H. , 'Effect of alcohol consumption on systemic markers of inflammation ' (2001 ) 357 Lancet : 763 -767 .
Libbi, P.: Inflammation in atherosclerosis. Nature, 2002, 420, 868–874.
Libbi P. , 'Inflammation in atherosclerosis ' (2002 ) 420 Nature : 868 -874 .
Senn, J. J., Klover, P. J., Nowak, I. A., et al.: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes, 2002, 51, 3391–3399.
Nowak I. A. , 'Interleukin-6 induces cellular insulin resistance in hepatocytes ' (2002 ) 51 Diabetes : 3391 -3399 .
Vázquez-Agell, M., Sacanella, E., Tobias, E., et al.: Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J. Nutr., 2007, 137, 2279–2284.
Tobias E. , 'Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk ' (2007 ) 137 J. Nutr. : 2279 -2284 .
Hill, D. J., Hogg, J.: Growth factor control of pancreatic β cell hyperplasia. Baillieres Clin. Endocrinol. Metab., 1991, 5, 689–698.
Hogg J. , 'Growth factor control of pancreatic β cell hyperplasia ' (1991 ) 5 Baillieres Clin. Endocrinol. Metab. : 689 -698 .
Brand, S. J., Tagerud, S., Lambert, P., et al.: Pharmacological treatment of chronic diabetes by stimulating pancreatic β-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol. Toxicol., 2002, 91, 414–420.
Lambert P. , 'Pharmacological treatment of chronic diabetes by stimulating pancreatic β-cell regeneration with systemic co-administration of EGF and gastrin ' (2002 ) 91 Pharmacol. Toxicol. : 414 -420 .